Shopping Cart

Remove All

Your shopping cart is currently empty

Proceed to checkout Continue shopping

KW-8232

Name: KW-8232
Brand: TargetMol
SKU: T36762
Rating: 4.5 (1 reviews)

😃Good

Catalog No. T36762Cas No. 217813-15-5

KW-8232, an orally active anti-osteoporotic agent, reduces the biosynthesis of PGE2 [1].

KW-8232

😃Good

Catalog No. T36762Cas No. 217813-15-5

KW-8232, an orally active anti-osteoporotic agent, reduces the biosynthesis of PGE2 [1].

Pack Size	Price	USA Warehouse	Global Warehouse
25 mg	$1,520	6-8 weeks	6-8 weeks
50 mg	$1,980	6-8 weeks	6-8 weeks
100 mg	$2,500	6-8 weeks	6-8 weeks

Add to Cart

Add to Quotation

In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]

All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Questions

Resource Download

Product Introduction

Bioactivity

Description	KW-8232, an orally active anti-osteoporotic agent, reduces the biosynthesis of PGE2 [1].
In vitro	KW-8232 is an anti-osteoporotic agent that reduces PGE2 biosynthesis in mouse osteoblastic cells[1] and exhibits anti-viral activity against SARS-CoV-2 (EC50 ~1.2 μM)[2].
In vivo	KW-8232 (3, 10, 30 mg/kg, p.o.) significantly increases femoral bone mineral density (BMD) in immobilized rat legs and modulates immobilization-induced abnormal bone turnover. At 30 mg/kg, it markedly reduces urinary calcium excretion, pyridinoline, and deoxypyridinoline—markers of bone resorption—in neurectomized rats. KW-8232's inhibition of bone loss may be linked to decreased prostaglandin (PG)-stimulated bone resorption through regulation of PGE2 production[1].

Chemical Properties

Molecular Weight	705.27
Formula	C₃₇H₄₁ClN₄O₆S
Cas No.	217813-15-5
Smiles	CS(O)(=O)=O.CN(C)CCn1c(C(=O)N2CCN(CC2)c2ccccc2Cl)c(C(c2ccc(O)cc2)c2ccc(O)cc2)c2ccccc12

Storage & Solubility Information

Storage

Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Solubility Information

DMSO: 125 mg/mL (177.24 mM), Sonication is recommended.

In Vivo Formulation

10% DMSO+90% Corn Oil: 3.3 mg/mL (4.68 mM), Sonication is recommended.

Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.

Solution Preparation Table

DMSO

	1mg	5mg	10mg	50mg
1 mM	1.4179 mL	7.0895 mL	14.1790 mL	70.8948 mL
5 mM	0.2836 mL	1.4179 mL	2.8358 mL	14.1790 mL
10 mM	0.1418 mL	0.7089 mL	1.4179 mL	7.0895 mL
20 mM	0.0709 mL	0.3545 mL	0.7089 mL	3.5447 mL
50 mM	0.0284 mL	0.1418 mL	0.2836 mL	1.4179 mL
100 mM	0.0142 mL	0.0709 mL	0.1418 mL	0.7089 mL

Calculator

Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:

For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments

and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent

10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH₂O , the resulting working solution concentration would be 2 mg/mL.

Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSO TargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSO TargetMol | reagent stock solution to 400 μL PEG300 and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH₂O TargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.

All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

KW-8232KW8232KW 8232

KW-8232

KW-8232

Featured Recommendations

Resource Download

Product Introduction

Calculator

In Vivo Formulation Calculator (Clear solution)

Dose Conversion

Tech Support

Keywords